Sustainability & Climate

A new strategic investment in My Pediatric Doctor aims to give families on-demand virtual access to pediatricians, tackling a growing need for care.

Half of U.S. shoppers now fear artificial ingredients, a new study finds. This is fueling a massive push for cleaner labels and stricter safety laws.

A new report shows most medical practices are flying blind, with only 7% confident in tracking revenue, leading to massive, preventable financial losses.

The iconic Grateful Dead partners with Host Defense for mushroom gummies, a move blending counter-culture legacy with the booming wellness market.

Magnum becomes Coachella's first frozen dessert sponsor, signaling a major shift in festival marketing with immersive, Instagram-worthy brand experiences.

With new high-protein flavors, Forager Project is betting on a unique cashew-based recipe to win over consumers disappointed by other dairy-free options.

As smugglers take to the sea in high-tech subs, companies like Jeffs' Brands are betting on AI-driven underwater security to turn the tide.

With a record $1.03B infusion, The Audacious Project is backing 10 bold new ventures aimed at solving humanity’s most intractable global problems.

A new animated video, voiced by a father and his daughter, offers hope and understanding to children battling a rare and life-threatening liver disease.

A new multi-year deal between a top gym and gear brand aims to redefine the climbing experience, fueled by the sport's growing Olympic spotlight.

Carson Daly and Gracie Gold to be honored at AFSP's Lifesavers Gala, highlighting the growing power of celebrity voices in suicide prevention.

Director Valerio Zanoli's new documentary doesn't just raise awareness; its profits build homes, challenging how we fight the global housing crisis.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

As tax fraud spikes, Allstate unveils an industry-first plan to give victims their stolen refund money upfront, tackling a growing financial nightmare.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.

With 80% of Indian diets lacking protein, the fast-food giant is serving up a science-backed solution. But can a burger truly bridge a national nutrition gap?

The bioprocessing leader posted robust 2025 earnings, outperforming the market with strategic innovation and a major expansion into Asian markets.

Facing SEC delays, Aptose Biosciences secures an $11.1M lifeline from its acquirer, Hanmi, highlighting financial strain as the critical deal moves forward.

Cullinan Therapeutics heads to key investor conferences, ready to showcase its T-cell engager platform for both cancer and challenging autoimmune diseases.

With no approved therapies for Hepatitis E, Atea Pharmaceuticals' new drug shows potent preclinical results, offering a potential lifeline for vulnerable patients.